title: ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
authors.forename: Vallerie V
authors.initials: VV
authors.lastname: McLaughlin
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Archer
authors.forename: David B
authors.initials: DB
authors.lastname: Badesch
authors.forename: Robyn J
authors.initials: RJ
authors.lastname: Barst
authors.forename: Harrison W
authors.initials: HW
authors.lastname: Farber
authors.forename: Jonathan R
authors.initials: JR
authors.lastname: Lindner
authors.forename: Michael A
authors.initials: MA
authors.lastname: Mathier
authors.forename: Michael D
authors.initials: MD
authors.lastname: McGoon
authors.forename: Myung H
authors.initials: MH
authors.lastname: Park
authors.forename: Robert S
authors.initials: RS
authors.lastname: Rosenson
authors.forename: Lewis J
authors.initials: LJ
authors.lastname: Rubin
authors.forename: Victor F
authors.initials: VF
authors.lastname: Tapson
authors.forename: John
authors.initials: J
authors.lastname: Varga
mesh_terms: D000465:Algorithms; D000572:American Heart Association; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006328:Cardiac Catheterization; D065128:Endothelin Receptor Antagonists; D011464:Epoprostenol / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D008403:Mass Screening; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D012955:Societies, Medical; D014481:United States
chemical_list: D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D010726:Phosphodiesterase Inhibitors; D011464:Epoprostenol